Corticotropin-releasing factor-induced production of cyclic AMP by human peripheral blood immunocytes

Vijendra K. Singh, Sy Jye Christine Leu

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

The immunomodulating properties of a neuropeptide hormone, corticotropin-releasing factor (CRF), led us to investigate its effect on cAMP production by human peripheral blood mononuclear cells (MNC). In response to stimulation with CRF (100 nM), a statistically significant (P = 0.019) increase occurred in the amount of cAMP produced by MNC. Purified monocytes, but not lymphocytes, also displayed a significant (P = 0.01) increase (8- to 10-fold) in intracellular cAMP after treatment with CRF (100 nM). The antagonist α-helical CRF9-41 (100 nM) counteracted the cAMP increase induced by CRF (100 nM). The CRF-induced cAMP production was augmented by pretreatment of MNC with a cAMP-dependent protein kinase (PKA) peptide inhibitor (PI20), but was virtually unaffected by the protein kinase C (PKC) inhibitor H7, suggesting a role for cAMP signalling. Moreover, the CRF-stimulated cAMP level was reduced to baseline by intracellular Ca2+ antagonist HA1004, indicating a role for Ca2+-signalling. Based on these findings, it is concluded that cAMP and/or Ca2+ play a second messenger role in the CRF signal transduction pathway.

Original languageEnglish
Pages (from-to)239-245
Number of pages7
JournalImmunology Letters
Volume35
Issue number3
DOIs
Publication statusPublished - 1993
Externally publishedYes

Fingerprint

Corticotropin-Releasing Hormone
Cyclic AMP
Protein Kinase Inhibitors
Protein C Inhibitor
Second Messenger Systems
Cyclic AMP-Dependent Protein Kinases
Neuropeptides
Protein Kinase C
Monocytes
Signal Transduction
Blood Cells
Hormones
Lymphocytes
Peptides

Keywords

  • cAMP
  • Corticotropin-releasing factor
  • Immunomodulation
  • Neuroendocrine-immune axis
  • Neurohormone
  • Neuropeptide

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Corticotropin-releasing factor-induced production of cyclic AMP by human peripheral blood immunocytes. / Singh, Vijendra K.; Leu, Sy Jye Christine.

In: Immunology Letters, Vol. 35, No. 3, 1993, p. 239-245.

Research output: Contribution to journalArticle

@article{6948255a4a1c4df7bbce5d05fd1caac5,
title = "Corticotropin-releasing factor-induced production of cyclic AMP by human peripheral blood immunocytes",
abstract = "The immunomodulating properties of a neuropeptide hormone, corticotropin-releasing factor (CRF), led us to investigate its effect on cAMP production by human peripheral blood mononuclear cells (MNC). In response to stimulation with CRF (100 nM), a statistically significant (P = 0.019) increase occurred in the amount of cAMP produced by MNC. Purified monocytes, but not lymphocytes, also displayed a significant (P = 0.01) increase (8- to 10-fold) in intracellular cAMP after treatment with CRF (100 nM). The antagonist α-helical CRF9-41 (100 nM) counteracted the cAMP increase induced by CRF (100 nM). The CRF-induced cAMP production was augmented by pretreatment of MNC with a cAMP-dependent protein kinase (PKA) peptide inhibitor (PI20), but was virtually unaffected by the protein kinase C (PKC) inhibitor H7, suggesting a role for cAMP signalling. Moreover, the CRF-stimulated cAMP level was reduced to baseline by intracellular Ca2+ antagonist HA1004, indicating a role for Ca2+-signalling. Based on these findings, it is concluded that cAMP and/or Ca2+ play a second messenger role in the CRF signal transduction pathway.",
keywords = "cAMP, Corticotropin-releasing factor, Immunomodulation, Neuroendocrine-immune axis, Neurohormone, Neuropeptide",
author = "Singh, {Vijendra K.} and Leu, {Sy Jye Christine}",
year = "1993",
doi = "10.1016/0165-2478(93)90189-9",
language = "English",
volume = "35",
pages = "239--245",
journal = "Immunology Letters",
issn = "0165-2478",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Corticotropin-releasing factor-induced production of cyclic AMP by human peripheral blood immunocytes

AU - Singh, Vijendra K.

AU - Leu, Sy Jye Christine

PY - 1993

Y1 - 1993

N2 - The immunomodulating properties of a neuropeptide hormone, corticotropin-releasing factor (CRF), led us to investigate its effect on cAMP production by human peripheral blood mononuclear cells (MNC). In response to stimulation with CRF (100 nM), a statistically significant (P = 0.019) increase occurred in the amount of cAMP produced by MNC. Purified monocytes, but not lymphocytes, also displayed a significant (P = 0.01) increase (8- to 10-fold) in intracellular cAMP after treatment with CRF (100 nM). The antagonist α-helical CRF9-41 (100 nM) counteracted the cAMP increase induced by CRF (100 nM). The CRF-induced cAMP production was augmented by pretreatment of MNC with a cAMP-dependent protein kinase (PKA) peptide inhibitor (PI20), but was virtually unaffected by the protein kinase C (PKC) inhibitor H7, suggesting a role for cAMP signalling. Moreover, the CRF-stimulated cAMP level was reduced to baseline by intracellular Ca2+ antagonist HA1004, indicating a role for Ca2+-signalling. Based on these findings, it is concluded that cAMP and/or Ca2+ play a second messenger role in the CRF signal transduction pathway.

AB - The immunomodulating properties of a neuropeptide hormone, corticotropin-releasing factor (CRF), led us to investigate its effect on cAMP production by human peripheral blood mononuclear cells (MNC). In response to stimulation with CRF (100 nM), a statistically significant (P = 0.019) increase occurred in the amount of cAMP produced by MNC. Purified monocytes, but not lymphocytes, also displayed a significant (P = 0.01) increase (8- to 10-fold) in intracellular cAMP after treatment with CRF (100 nM). The antagonist α-helical CRF9-41 (100 nM) counteracted the cAMP increase induced by CRF (100 nM). The CRF-induced cAMP production was augmented by pretreatment of MNC with a cAMP-dependent protein kinase (PKA) peptide inhibitor (PI20), but was virtually unaffected by the protein kinase C (PKC) inhibitor H7, suggesting a role for cAMP signalling. Moreover, the CRF-stimulated cAMP level was reduced to baseline by intracellular Ca2+ antagonist HA1004, indicating a role for Ca2+-signalling. Based on these findings, it is concluded that cAMP and/or Ca2+ play a second messenger role in the CRF signal transduction pathway.

KW - cAMP

KW - Corticotropin-releasing factor

KW - Immunomodulation

KW - Neuroendocrine-immune axis

KW - Neurohormone

KW - Neuropeptide

UR - http://www.scopus.com/inward/record.url?scp=0027463271&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027463271&partnerID=8YFLogxK

U2 - 10.1016/0165-2478(93)90189-9

DO - 10.1016/0165-2478(93)90189-9

M3 - Article

VL - 35

SP - 239

EP - 245

JO - Immunology Letters

JF - Immunology Letters

SN - 0165-2478

IS - 3

ER -